TECH
Why Ivy‑League Hires Are Killing Biopharma R&D (And How Data‑Driven Hiring Saves the Day)
Hook The core problem isn’t a shortage of talent; it’s a hiring obsession with pedigree that blinds companies to the real engine of discovery: hands-on bench skill. A staggering 62% of newly hired senior scientists quit within 18 months, proving that elite diplomas don’t automatically translate into